FENC Fennec Pharmaceuticals Inc.

Fundamentals / CIK 0001211583 / USD

Fennec Pharmaceuticals Inc. reported $66.37M in revenue and net income of $2.03M for the trailing twelve months ended September 30, 2026 (up 57.3% year over year), with a 5.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FENC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$49.36M$24.68M$0-$26.21MFY 2016 Revenue: $0FY 2016 Net Income: -$2.79M2016FY 2017 Revenue: $0FY 2017 Net Income: -$7.05M2017FY 2018 Revenue: $0FY 2018 Net Income: -$9.89M2018FY 2019 Revenue: $0FY 2019 Net Income: -$12.78M2019FY 2020 Revenue: $200KFY 2020 Net Income: -$18.11M2020FY 2021 Net Income: -$17.35M2021FY 2022 Revenue: $1.53MFY 2022 Net Income: -$23.71M2022FY 2023 Revenue: $21.25MFY 2023 Net Income: -$16.05M2023FY 2024 Revenue: $47.54MFY 2024 Net Income: -$436K2024FY 2025 Revenue: $44.64MFY 2025 Net Income: -$9.74M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $44.64M $47.54M $21.25M $1.53M -- $200K $0 $0 $0 $0
Cost of Revenue -- -- $1.26M $86K -- -- -- -- -- --
Gross Profit -- -- $19.99M $1.45M -- -- -- -- -- --
Research & Development $250K $307K $56K $3.53M $4.98M $5.11M $5.61M $5.01M $1.94M $472K
Selling, General & Admin $46.91M $41.48M $32.71M $20.51M -- -- -- -- -- --
Total Operating Expenses $50.92M $44.97M $34.02M $24.04M $17.22M $18.05M $13.01M -- -- --
Operating Income -$6.28M $2.57M -$12.77M -$22.59M -$17.22M -$17.89M -$13.01M -$10.41M -$6.95M -$2.87M
Interest Income $787K $1.68M $441K -- -- -- -- -- -- --
Interest Expense $2.08M $4.07M $3.39M -- -- -- -- -- -- --
Income Before Tax -$9.63M -$71K -$16.05M -- -- -- -- -- -$7.05M -$2.79M
Income Tax Expense $106K $365K -- $0 $0 $0 $0 $0 $0 $0
Net Income -$9.74M -$436K -$16.05M -$23.71M -$17.35M -$18.11M -$12.78M -$9.89M -$7.05M -$2.79M
Basic EPS -$0.34 -$0.02 -$0.60 -$0.90 -$0.67 -$0.76 -$0.64 -$0.52 -$0.47 -$0.22
Diluted EPS -$0.34 -$0.02 -$0.60 -$0.90 -$0.67 -$0.76 -$0.64 -$0.52 -$0.47 -$0.22
Basic Shares Outstanding 28.6M 27.3M 26.6M 26.3M 26.0M 23.7K 19.9M 18.9M 15.0M 12.8M
Diluted Shares Outstanding 28.6M 27.3M 26.6M 26.3M 26.0M 23.7K 19.9M 18.9M 15.0M 12.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $19.61M $17.87M $15.11M $13.78M $12.46M $9.65M $8.75M $7.92M
Research & Development $154K $118K $49K $20K $29K $107K $94K $50K
Selling, General & Admin $13.96M $15.30M $14.61M $14.55M $11.96M $11.31M $9.09M $8.14M
Total Operating Expenses $14.95M $16.14M $15.23M $16.33M $12.65M $12.38M $9.56M $8.86M
Operating Income $4.65M $1.74M -$119K -$2.55M -$189K -$2.73M -$808K -$934K
Interest Income $319K $287K $339K $228K $152K $171K $236K $399K
Interest Expense $1.0K $3.0K $7.0K $308K $586K $594K $592K $966K
Income Before Tax $4.97M $2.02M -- -- -$638K -$3.15M -- --
Income Tax Expense $332K $42K -- $106K $0 $0 $0 --
Net Income $4.64M $1.97M $201K -$4.79M -$638K -$3.15M -$1.17M -$1.99M
Basic EPS $0.13 $0.06 $0.01 -- -$0.02 -$0.11 -$0.04 --
Diluted EPS $0.12 $0.05 $0.01 -- -$0.02 -$0.11 -$0.04 --
Basic Shares Outstanding 35.1M 34.5M 34.3M -- 27.9M 27.7M 27.6M --
Diluted Shares Outstanding 38.1M 36.4M 35.5M -- 27.9M 27.7M 27.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Sep 30 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $36.79M $26.63M $13.27M $12.40M $23.77M $21.10M $30.34M $13.65M $22.78M $28.26M
Cash & Short-Term Investments $36.79M $26.63M $13.27M $12.40M $23.77M $21.10M $30.34M $13.65M $22.78M $28.26M
Other Current Assets $1.73M $466K $44K $20K $63K $253K $276K $8.0K $1.0K $13K
Total Current Assets $67.04M $44.12M $26.86M $19.90M $26.73M $22.39M $31.42M $13.88M $22.95M $28.40M
Other Non-Current Assets $717K $822K $816K -- -- -- -- -- -- --
Total Non-Current Assets $3.51M $822K $6.0K $82K $211K $27K $0 $262K $0 $0
Total Assets $70.55M $44.95M $26.86M $19.98M $26.94M $22.41M $31.42M $14.15M $22.95M $28.40M
Accounts Payable $4.63M $3.24M $3.78M $2.94M $2.39M $777K $1.57M $1.61M $1.03M $855K
Deferred Revenue (Current) $248K $248K -- -- -- -- -- -- -- --
Total Current Liabilities $10.52M $6.92M $7.55M $3.91M $4.61M $1.65M $2.35M $2.27M $1.64M $1.64M
Long-Term Debt -- $19.34M $30.93M $25.64M $24.90M $5.00M -- -- -- --
Deferred Revenue (Non-Current) $24.56M $24.56M $2.0K -- -- -- -- -- -- --
Total Non-Current Liabilities $24.56M $43.90M $30.93M $25.65M $24.90M $4.99M $0 $0 $0 $0
Total Liabilities $35.08M $50.82M $38.49M $29.56M $29.51M $6.64M $2.35M $2.27M $1.64M $1.64M
Total Debt (incl. Leases) -- $19.34M $30.95M $25.67M $24.90M $5.00M -- -- -- --
Common Stock $189.9M $145.6M $144.3M $143.6M $142.6M $140.8M $140.7M $106.4M $106.4M $103.0M
Retained Earnings -$229.4M -$219.7M -$219.2M $215.6M -$203.2M -$179.5M -$162.1M -$144.0M -$131.3M -$121.4M
Accumulated Other Comp. Income $1.24M $1.24M $1.24M $1.24M $1.24M $1.24M $1.24M $1.24M $1.24M $1.24M
Total Stockholders' Equity $35.47M -$5.87M -$11.62M -$10.53M -$2.57M $15.77M $29.07M $11.88M $21.31M $26.76M
Total Equity $35.47M -$5.87M -$11.62M -$10.53M -$2.57M $15.77M $29.07M $11.88M $21.31M $26.76M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $48.68M $41.25M $40.18M $36.79M $21.95M $18.70M $22.68M $26.63M
Cash & Short-Term Investments $48.68M $41.25M $40.18M $36.79M $21.95M $18.70M $22.68M $26.63M
Other Current Assets $1.42M $1.98M $2.62M $1.73M $898K $965K $1.00M $466K
Total Current Assets $80.95M $72.50M $66.88M $67.04M $46.06M $40.79M $42.98M $44.12M
Other Non-Current Assets $640K $666K $691K $717K $743K $768K $794K $822K
Total Non-Current Assets $2.59M $3.25M $4.94M $3.51M $3.20M $4.08M $3.43M $822K
Total Assets $83.54M $75.75M $71.82M $70.55M $49.26M $44.88M $46.40M $44.95M
Accounts Payable $4.61M $5.52M $6.28M $4.63M $5.87M $5.94M $5.28M $3.24M
Deferred Revenue (Current) $2.81M $3.18M $248K $248K $248K $248K $248K $248K
Total Current Liabilities $13.24M $12.39M $9.59M $10.52M $9.81M $8.41M $8.37M $6.92M
Long-Term Debt -- -- -- -- $19.38M $19.36M $19.35M $19.34M
Deferred Revenue (Non-Current) $21.11M $20.92M $24.56M $24.56M $24.56M $24.56M $24.56M $24.56M
Total Non-Current Liabilities $21.11M $20.92M $24.56M $24.56M $43.94M $43.92M $43.91M $43.90M
Total Liabilities $34.35M $33.31M $34.15M $35.08M $53.75M $52.34M $52.28M $50.82M
Total Debt (incl. Leases) -- -- -- -- $19.38M $19.36M $19.35M $19.34M
Common Stock $194.1M $193.2M $191.2M $189.9M $147.7M $146.2M $146.0M $145.6M
Retained Earnings -$222.6M -$227.2M -$229.2M -$229.4M -$224.6M -$224.0M -$220.8M -$219.7M
Accumulated Other Comp. Income $1.24M $1.24M $1.24M $1.24M $1.24M $1.24M $1.24M $1.24M
Total Stockholders' Equity $49.19M $42.44M $37.67M $35.47M -$4.49M -$7.46M -$5.88M -$5.87M
Total Equity $49.19M $42.44M $37.67M $35.47M -$4.49M -$7.46M -$5.88M -$5.87M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$9.74M -$436K -$16.05M -$23.71M -$17.35M -$18.11M -$12.78M -$9.89M -$7.05M -$2.79M
Stock-Based Compensation $7.03M $5.06M $5.35M $4.09M $3.75M $2.79M $2.67M $1.82M $1.52M $615K
Change in Receivables -$12.44M -$7.87M -$7.27M -$1.54M -- -- -- -- -- --
Change in Inventory -$1.28M $579K -$1.58M -$576K -- -- -- -- -- --
Change in Payables $1.39M -$537K $1.39M $1.61M -$794K -$41K $580K $177K $611K -$54K
Operating Cash Flow -$12.47M $26.98M -$17.14M -$18.06M -$14.22M -$15.60M -$9.06M -$7.83M -$3.64M -$2.12M
Investing Cash Flow -- -- -- -- -- -- -- $0 $0 $0
Common Stock Issued -- -- -- -- -- $31.97M $0 $0 $27.38M $5.00M
Financing Cash Flow $22.63M -$13.62M $6.64M $20.73M $4.98M $32.29M -$71K $2.35M $27.98M $5.11M
Net Change in Cash $10.15M $13.37M -$10.51M $2.67M -$9.24M $16.69M -$9.13M -$5.48M $24.33M $2.98M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $4.64M $1.97M $201K -$4.79M -$637K -$3.15M -$1.17M -$1.99M
Stock-Based Compensation $1.35M $1.77M $990K $2.52M $2.22M $1.49M $798K $1.12M
Change in Receivables -$528K -$4.22M $4.51M -$3.46M -$3.44M -$265K -$5.28M -$175K
Change in Inventory $257K -$518K -$291K $139K -$276K -$797K -$344K $65K
Change in Payables -$909K -$765K $1.65M -$1.23M -$75K $661K $2.04M -$626K
Operating Cash Flow $6.68M $50K $2.38M -$5.96M $1.49M -$3.69M -$4.32M -$1.47M
Financing Cash Flow $753K $1.02M $1.01M $20.80M $1.75M -$284K $359K -$12.21M
Net Change in Cash $7.43M $1.07M $3.39M $14.84M $3.24M -$3.97M -$3.96M -$13.69M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- 94.1% 94.4% -- -- -- -- -- --
Operating Margin -14.1% 5.4% -60.1% -1471.6% -- -8942.5% -- -- -- --
Net Profit Margin -21.8% -0.9% -75.5% -1544.9% -- -9054.5% -- -- -- --
Return on Equity (ROE) -27.5% -- -- -- -110.0% -62.3% -107.6% -46.4% -26.3% -78.1%
Return on Assets (ROA) -13.8% -1.0% -59.7% -88.0% -77.4% -57.6% -90.3% -43.1% -24.8% -70.2%
Current Ratio 6.37x 6.38x 3.56x 5.80x 13.54x 13.39x 6.11x 14.02x 17.28x --
Quick Ratio 3.50x 3.85x 1.76x 5.16x 12.76x 12.93x 6.01x 13.92x 17.19x 9.77x
Debt to Equity -- -- -- -- 0.32x -- -- -- -- --
Revenue Growth (YoY) -6.1% +123.7% +1284.5% -- -- -- -- -- -- --
Gross Profit Growth (YoY) -- -- +1279.8% -- -- -- -- -- -- --
Operating Income Growth (YoY) -344.6% -- -- -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -146.2% -- -- -- -- -- -- -- -- --
5Y Revenue / Share Growth -81.5% -- -- -- -- -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -375.0% -- -100.0%
10Y Net Income / Share Growth -- -- -418.1% -- -100.1% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin 5.6% -1.9% -11.0% -14.1% -12.0% -29.1% -38.8% 5.4%
Net Profit Margin 3.1% -5.5% -16.4% -21.8% -17.9% -36.1% -46.7% -0.9%
Return on Equity (ROE) 4.1% -7.7% -22.2% -27.5% -- -- -- --
Return on Assets (ROA) 2.4% -4.3% -11.7% -13.8% -14.1% -26.8% -31.1% -1.0%
Current Ratio 6.11x 5.85x 6.98x 6.37x 4.69x 4.85x 5.13x 6.38x
Quick Ratio 3.68x 3.33x 4.19x 3.50x 2.24x 2.22x 2.71x 3.85x
Revenue Growth (YoY) +57.3% +85.2% +72.6% +73.8% +78.7% +32.9% -65.5% -18.6%
Operating Income Growth (YoY) -- -- -- -- -- -- -105.9% --
Net Income Growth (YoY) -- -- -- -- -- -- -109.1% --
EPS Growth (YoY) -- -- -- -- -- -- -108.5% --
Operating Cash Flow Growth (YoY) +347.6% -- -- -- -- -- -111.1% --
Source: SEC EDGAR CompanyFacts (CIK 0001211583) · from June 30, 1998 Data through September 30, 2026 · synced Nov 20, 2026, 05:38 UTC · Open in terminal